XML 59 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Quarterly Financial Data
 12 Months Ended
Dec. 31, 2011
QUARTERLY FINANCIAL DATA (unaudited) [Abstract]  
Quarterly Financial Data
QUARTERLY FINANCIAL DATA (unaudited)

The following table sets forth unaudited consolidated statements of operations data for the eight quarters in the period ended December 31, 2011. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods.
 
 
Quarter Ended
 
 
Mar. 31,
 
Jun. 30,
 
Sep. 30,
 
Dec. 31,
 
Mar. 31,
 
Jun. 30,
 
Sep. 30,
 
Dec. 31,
 
 
2011
 
2011
 
2011
 
2011
 
2010
 
2010
 
2010
 
2010
 
 
(Unaudited, In thousands, except share and per share information)
Revenues
 
$
61,130

 
$
39,746

 
$
50,585

 
$
20,795

 
$
39,772

 
$
15,006

 
$
63,949

 
$
13,102

Operating costs and expenses:
 
 

 
 

 
 

 
 
 
 

 
 

 
 

 
 

Cost of revenues:
 
 

 
 

 
 

 
 
 
 

 
 

 
 

 
 

Inventor royalties
 
13,089

 
8,588

 
15,592

 
6,458

 
3,911

 
2,877

 
14,508

 
3,996

Contingent legal fees
 
9,367

 
13,039

 
12,328

 
5,547

 
4,407

 
3,465

 
9,739

 
2,295

Litigation and licensing expenses - patents
 
3,538

 
3,761

 
3,501

 
2,205

 
3,696

 
4,433

 
2,835

 
2,927

Amortization of patents
 
3,772

 
2,600

 
1,946

 
1,427

 
1,703

 
1,876

 
1,963

 
1,389

Verdict insurance proceeds
 
—

 
—

 
(12,451
)
 
—

 
—

 
—

 
—

 
—

Verdict insurance proceeds related costs
 
—

 
—

 
7,661

 
—

 
—

 
—

 
—

 
—

Marketing, general and administrative expenses (including non-cash stock compensation expense)
 
9,981

 
8,302

 
8,748

 
8,662

 
6,332

 
6,056

 
6,388

 
6,291

Research, consulting and other expenses - business development
 
708

 
1,335

 
850

 
1,445

 
372

 
453

 
461

 
835

Total operating costs and expenses
 
40,455

 
37,625

 
38,175

 
25,744

 
20,421

 
19,160

 
35,894

 
17,733

Operating income (loss)
 
20,675

 
2,121

 
12,410

 
(4,949
)
 
19,351

 
(4,154
)
 
28,055

 
(4,631
)
Other income (expense)
 
29

 
24

 
25

 
18

 
19

 
20

 
44

 
52

Income (loss) before provision for income taxes
 
20,704

 
2,145

 
12,435

 
(4,931
)
 
19,370

 
(4,134
)
 
28,099

 
(4,579
)
(Provision) benefit for income taxes
 
(7,148
)
 
(306
)
 
(1,889
)
 
635

 
(321
)
 
13

 
(317
)
 
(1,115
)
Net income (loss) including noncontrolling interests
 
13,556

 
1,839

 
10,546

 
(4,296
)
 
19,049

 
(4,121
)
 
27,782

 
(5,694
)
Net (income) loss attributable to noncontrolling interests
 
(1,203
)
 
300

 
257

 
107

 
(537
)
 
255

 
(3,107
)
 
424

Net income (loss) attributable to Acacia Research Corporation
 
$
12,353

 
$
2,139

 
$
10,803

 
$
(4,189
)
 
$
18,512

 
$
(3,866
)
 
$
24,675

 
$
(5,270
)
Net income (loss) per common share attributable to Acacia Research Corporation:
 
 

 
 

 
 

 
 

 
 

 
 

 
 

 
 

Basic income (loss) per share
 
$
0.35

 
$
0.05

 
$
0.26

 
$
(0.10
)
 
$
0.60

 
$
(0.12
)
 
$
0.75

 
$
(0.16
)
Diluted income (loss) per share
 
$
0.34

 
$
0.05

 
$
0.25

 
$
(0.10
)
 
$
0.55

 
$
(0.12
)
 
$
0.70

 
$
(0.16
)
Weighted-average number of shares outstanding, basic
 
35,182,811

 
40,994,082

 
41,292,819

 
41,418,470

 
30,847,403

 
31,664,869

 
32,794,553

 
33,879,777

Weighted-average number of shares outstanding, diluted
 
36,448,005

 
42,453,782

 
42,857,880

 
41,418,470

 
33,411,093

 
31,664,869

 
35,105,354

 
33,879,777